⚡ Technology🌐 Global
FDA Advisors Unanimously Back Moderna's mRNA Vaccine After Months of Political Drama
Ars Technica·Friday, 19 June 2026
FDA advisory panel members have voted unanimously to recommend approval of Moderna's mRNA vaccine. The approval process had stalled after a Trump administration official refused to review the vaccine in February. The unanimous vote signals a strong scientific consensus in favour of the shot.
Why It Matters
Vaccine approvals in the US often influence global regulatory decisions, including in India. The political interference in the FDA's review process also highlights how health decisions can get caught in political crossfire.
🔒 Potential Impact + source link
Subscribe to unlock the impact analysis and original source for every story.
More from Technology
- Google Confirms Timeline for Android Developer Verification — Big Changes Hit in September
- Microsoft Finds New Malware That Steals Crypto via USB and Hides on Tor
- Apple Patches Year-Old Eavesdropping Bug in Beats Studio Buds — Multiple Brands Affected
- Quantum Error Correction Could Be Ready by 2028, Say Amazon and QuEra